Literature DB >> 18990503

Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.

Lidia Strigari1, Giorgio Arcangeli, Stefano Arcangeli, Marcello Benassi.   

Abstract

PURPOSE: To describe the radiation-induced acute rectal toxicity (ART) using a modified Lyman-Kutcher-Burman normal tissue complication probability model and parameters set, taking into account the overall treatment time. METHODS AND MATERIALS: A total of 160 patients underwent three-dimensional conformal radiotherapy to the prostate and seminal vesicles and were randomized to receive 80 Gy in 40 fractions within 8 weeks (Group A) or 62 Gy in 20 fractions within 5 weeks, 4 d/wk (Group B). An additional 52 patients (Group C) underwent intensity-modulated radiotherapy with a hypofractionation schedule consisting of 56 Gy, delivered in 16 fractions (4/wk) of 3.5 Gy. Patients were followed for ART weekly during treatment. The overall treatment time, rectal dose-volume histograms, and ART status, defined as Radiation Therapy Oncology Group Grade 2 or greater gastrointestinal toxicity, were used to determine the modified Lyman-Kutcher-Burman model parameters. The m and n values were obtained from the cohort, and the tolerance doses for 50% complication probability for uniform irradiation [TD(50)(1)(k)] were obtained for each fractionation schedule indicated with k.
RESULTS: Of 212 patients treated with localized prostate radiotherapy, 65 developed Grade for > or = 1 week during treatment. The m and n value was 0.17 and 0.08, respectively. The TD(50)(1)(k) parameter was 79, 62.5, and 53 Gy, respectively for Group A, B, and C.
CONCLUSION: The optimized modified Lyman-Kutcher-Burman normal tissue complication probability model allowed us to describe the ART data from conventional and hypofractionated regimens, using the dose-volume histograms and overall treatment time. This model could prove useful in designing hypofractionation schedules to reduce the incidence of ART.

Entities:  

Mesh:

Year:  2008        PMID: 18990503     DOI: 10.1016/j.ijrobp.2008.07.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

Review 1.  21 years of biologically effective dose.

Authors:  J F Fowler
Journal:  Br J Radiol       Date:  2010-07       Impact factor: 3.039

2.  Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.

Authors:  Susan L Tucker; Jeff M Michalski; Walter R Bosch; Radhe Mohan; Lei Dong; Kathryn Winter; James A Purdy; James D Cox
Journal:  Radiother Oncol       Date:  2012-06-05       Impact factor: 6.280

3.  IsoBED: a tool for automatic calculation of biologically equivalent fractionation schedules in radiotherapy using IMRT with a simultaneous integrated boost (SIB) technique.

Authors:  Vicente Bruzzaniti; Armando Abate; Massimo Pedrini; Marcello Benassi; Lidia Strigari
Journal:  J Exp Clin Cancer Res       Date:  2011-05-09

4.  Hypofractionated radiotherapy versus conventional radiotherapy in patients with intermediate- to high-risk localized prostate cancer: a meta-analysis of randomized controlled trials.

Authors:  Wei Guo; Yun-Chuan Sun; Jian-Qiang Bi; Xin-Ying He; Li Xiao
Journal:  BMC Cancer       Date:  2019-11-08       Impact factor: 4.430

5.  Reducing margins for abdominopelvic tumours in dogs: Impact on dose-coverage and normal tissue complication probability.

Authors:  Valeria Meier; Chris Staudinger; Stephan Radonic; Jürgen Besserer; Uwe Schneider; Linda Walsh; Carla Rohrer Bley
Journal:  Vet Comp Oncol       Date:  2021-01-06       Impact factor: 2.613

6.  Hypofractionated external-beam radiation therapy (HEBRT) versus conventional external-beam radiation (CEBRT) in patients with localized prostate cancer: a systematic review and meta-analysis.

Authors:  Tobias Engel Ayer Botrel; Otávio Clark; Antônio Carlos Lima Pompeo; Francisco Flávio Horta Bretas; Marcus Vinicius Sadi; Ubirajara Ferreira; Rodolfo Borges Dos Reis
Journal:  Core Evid       Date:  2013-03-07

7.  Efficacy and toxicity of external-beam radiation therapy for localised prostate cancer: a network meta-analysis.

Authors:  Z Zhu; J Zhang; Y Liu; M Chen; P Guo; K Li
Journal:  Br J Cancer       Date:  2014-04-15       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.